Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity-Reference-Cited by-同舟云学术

Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity

Published:2007-04-06 Issue:2 Volume:9 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Vincent-Salomon Anne,Gruel Nadège,Lucchesi Carlo,MacGrogan Gaëtan,Dendale Remi,Sigal-Zafrani Brigitte,Longy Michel,Raynal Virginie,Pierron Gaëlle,de Mascarel Isabelle,Taris Corinne,Stoppa-Lyonnet Dominique,Pierga Jean-Yves,Salmon Rémy,Sastre-Garau Xavier,Fourquet Alain,Delattre Olivier,de Cremoux Patricia,Aurias Alain

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/bcr1666.pdf

Reference42 articles.

1. Ridolfi RL, Rosen PP, Port A, Kinne D, Mike V: Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up. Cancer. 1977, 40: 1365-1385. 10.1002/1097-0142(197710)40:4<1365::AID-CNCR2820400402>3.0.CO;2-N.

2. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, et al: Molecular portraits of human breast tumours. Nature. 2000, 406: 747-752. 10.1038/35021093.

3. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, et al: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001, 98: 10869-10874. 10.1073/pnas.191367098.

4. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, et al: Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA. 2003, 100: 8418-8423. 10.1073/pnas.0932692100.

5. van de Rijn M, Perou CM, Tibshirani R, Haas P, Kallioniemi O, Kononen J, Torhorst J, Sauter G, Zuber M, Kochli OR, et al: Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am J Pathol. 2002, 161: 1991-1996.

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Triple-negative breast cancer: from none to multiple therapeutic targets in two decades;Frontiers in Oncology;2023-11-09

2. p53 controls choice between apoptotic and non-apoptotic death following DNA damage;2023-01-18

3. Spatial Technologies: A Game Changer for Studying the Tumor Microenvironment;Handbook of Cancer and Immunology;2023

4. Spatial Technologies: A Game Changer for Studying the Tumor Microenvironment;Handbook of Cancer and Immunology;2023

5. High cyclin E1 protein, but not gene amplification, is prognostic for basal‐like breast cancer;The Journal of Pathology: Clinical Research;2022-04-06